Chicago Breast & Lymphedema Symposium 2016
Target Audience
Learning Objectives
After participating in this conference, participants will be able to:
- Describe the most appropriate therapies for breast cancer, breast reconstruction, and lymphedema;
- Recognize optimal patients for pre-pectoral implant reconstruction;
- Identify multidisciplinary strategies available for addressing complex patient diagnoses;
- Select donor sites for autologous tissue reconstruction;
- Determine the expected outcomes from treatment of lymphedema based on analyzed case studies and examples;
- Relate how to perform various surgical treatments of lymphedema;
- State how to apply knowledge of different patient diagnoses to clinical practice
- Describe the clinical implications and physiological impact of autologous breast reconstruction in terms of physical and occupational therapy in an effort to restore patient’s functional mobility and quality of life;
- Determine opportunities to work collaboratively in interprofessional teams to enhance the quality of patient care and clinical outcomes in the therapeutic areas of breast cancer, breast reconstruction, and lymphedema.
- 11.25 AMA PRA Category 1 Credit™
- 11.25 Occupational Therapist
- 11.25 Participation
- 11.25 Physical Therapist
The 2016 Chicago Breast and Lymphedema Symposium will be hosted at The Virgin Hotel Chicago. For information on how to book a room, please click here.
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
PLANNING COMMITTEE
Associate Professor of Surgery
Section of General Surgery
The University of Chicago Medicine
Professor of Surgery
Section of Plastic and Reconstructive Surgery
The University of Chicago Medicine
Associate Professor of Surgery
Section of Plastic and Reconstructive Surgery
The University of Chicago Medicine
Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with anycommercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.
The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 11.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Applicable to physicians and allied healthcare professionals only. Expires June 15, 2016.
Residents can send a letter of verification to cme@bsd.uchicago.edu to acquire a special discount code!
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office at 773-795-0333 or via email at ekuzma@surgery.bsd.uchicago.edu.
CANCELLATION POLICY If you cancel your participation in this conference, your registration fee, less a $100 administrative fee, will be refunded when written notification is received by September 12, 2016. No refunds will be made after September 12, 2016.